1. Home
  2. NTRA vs OMC Comparison

NTRA vs OMC Comparison

Compare NTRA & OMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$243.30

Market Cap

27.0B

Sector

Health Care

ML Signal

N/A

Logo Omnicom Group Inc.

OMC

Omnicom Group Inc.

N/A

Current Price

$78.69

Market Cap

25.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
OMC
Founded
2003
1944
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
25.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
OMC
Price
$243.30
$78.69
Analyst Decision
Strong Buy
Buy
Analyst Count
15
6
Target Price
$249.53
$92.83
AVG Volume (30 Days)
1.1M
3.5M
Earning Date
02-26-2026
02-04-2026
Dividend Yield
N/A
4.07%
EPS Growth
N/A
N/A
EPS
N/A
6.79
Revenue
$2,116,676,000.00
$16,065,300,000.00
Revenue This Year
$33.42
$4.67
Revenue Next Year
$16.96
$24.99
P/E Ratio
N/A
$11.58
Revenue Growth
38.17
4.13
52 Week Low
$125.38
$68.37
52 Week High
$256.36
$89.35

Technical Indicators

Market Signals
Indicator
NTRA
OMC
Relative Strength Index (RSI) 57.62 52.27
Support Level $226.66 $77.69
Resistance Level $243.69 $81.25
Average True Range (ATR) 9.63 2.09
MACD -0.30 -0.22
Stochastic Oscillator 56.41 48.01

Price Performance

Historical Comparison
NTRA
OMC

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About OMC Omnicom Group Inc.

Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, ad placement, and public relations. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.

Share on Social Networks: